Oxford Biomedica (OXB) News Today GBX 640.65 +14.65 (+2.34%) As of 12:28 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock OXB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period OXB acquires US manufacturing site, accelerating expansionOctober 7 at 11:21 AM | investing.comOxford Biomedica says existing financial guidance ‘remains unchanged’October 7 at 11:21 AM | msn.comCanaccord Genuity Group Reiterates Buy Rating for Oxford Biomedica (LON:OXB)October 7 at 11:01 AM | marketbeat.comOxford BioMedica narrows interim loss, backs annual outlookSeptember 23, 2025 | lse.co.ukOxford Biomedica beats revenue expectations, narrows losses in first halfSeptember 23, 2025 | za.investing.comOxford Biomedica (LON:OXB) Reaches New 1-Year High - Should You Buy?September 22, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Reaches New 52-Week High - What's Next?September 12, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Sets New 12-Month High - Here's WhySeptember 6, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Reaches New 52-Week High on Analyst UpgradeAugust 29, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Given New GBX 930 Price Target at Royal Bank Of CanadaAugust 28, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Sets New 1-Year High - Here's WhyAugust 23, 2025 | marketbeat.comDame Kay Davies Sells 4,563 Shares of Oxford Biomedica (LON:OXB) StockAugust 23, 2025 | insidertrades.comOxford Biomedica plc (LON:OXB) Insider Acquires £301,500 in StockAugust 19, 2025 | marketbeat.comRoch Doliveux Purchases 67,000 Shares of Oxford Biomedica plc (LON:OXB) StockAugust 19, 2025 | insidertrades.comOxford Biomedica (LON:OXB) Shares Up 12.5% - Should You Buy?August 18, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Hits New 1-Year High - What's Next?August 17, 2025 | marketbeat.comFrederic Doliveux Bought 18% More Shares In Oxford BiomedicaAugust 17, 2025 | finance.yahoo.comOxford Biomedica (LON:OXB) Earns Buy Rating from Peel HuntAugust 5, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Reaches New 1-Year High - Time to Buy?July 31, 2025 | marketbeat.comUK's Oxford Biomedica maintains annual outlookJuly 28, 2025 | reuters.comOxford Biomedica (LON:OXB) Given New GBX 400 Price Target at JPMorgan Chase & Co.July 15, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Shares Cross Below Two Hundred Day Moving Average - Here's What HappenedJuly 3, 2025 | marketbeat.comInsider Spends UK£37k Buying More Shares In Oxford BiomedicaJune 25, 2025 | finance.yahoo.comOxford Biomedica (LON:OXB) Share Price Passes Below 200-Day Moving Average - Time to Sell?June 25, 2025 | marketbeat.comOxford Biomedica completes acquisition of remaining stake in U.S. subsidiaryJune 24, 2025 | finance.yahoo.comHeather Preston Acquires 11,389 Shares of Oxford Biomedica plc (LON:OXB) StockJune 18, 2025 | insidertrades.comHeather Preston Buys 11,389 Shares of Oxford Biomedica plc (LON:OXB) StockJune 17, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Stock Price Crosses Below Two Hundred Day Moving Average - Here's What HappenedJune 10, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Stock Price Crosses Below 200 Day Moving Average - Time to Sell?May 25, 2025 | marketbeat.comOxford Biomedica announces executive share option grantsMay 17, 2025 | uk.investing.comOxford Biomedica (LON:OXB) Stock Price Crosses Below 200-Day Moving Average - Time to Sell?May 17, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Stock Price Passes Below 200-Day Moving Average - Should You Sell?May 9, 2025 | marketbeat.comOxford BioMedica PLC OXBMay 7, 2025 | morningstar.comMOxford Biomedica insider completes share transactionMay 2, 2025 | uk.investing.comOxford Biomedica (LON:OXB) Share Price Crosses Below Two Hundred Day Moving Average - What's Next?April 30, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Shares Up 12.1% - Here's What HappenedApril 12, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Posts Quarterly Earnings ResultsApril 11, 2025 | marketbeat.comOxford Biomedica reports FY24 EPS (GPB 41.75) vs. (GPB 163.11) last yearApril 9, 2025 | msn.comOxford Biomedica falls on lower EBITDA outlook despite strong revenue guideApril 9, 2025 | investing.comViroCell Biologics Appoints Viral Vector Expert as Special AdvisorMarch 28, 2025 | finance.yahoo.comOXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' categoryMarch 21, 2025 | markets.businessinsider.comOxford Biomedica (LON:OXB) Stock Price Passes Below 200-Day Moving Average - Here's WhyMarch 11, 2025 | marketbeat.comOxford Biomedica backs novel cystic fibrosis gene therapy trialFebruary 21, 2025 | investing.comBoehringer and partners commence gene therapy trial for cystic fibrosisFebruary 21, 2025 | msn.comBoehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosisFebruary 20, 2025 | markets.businessinsider.comNovel inhalable gene therapy trialed for people with cystic fibrosisFebruary 20, 2025 | msn.comSMALL-CAP WINNERS & LOSERS: Wilmington half-year profit fallsFebruary 17, 2025 | lse.co.ukOxford BioMedica shares fall as revenue to stay below 2022 levelFebruary 17, 2025 | lse.co.ukOxford Biomedica Share Chat (OXB)February 14, 2025 | lse.co.ukOxford Biomedica (LON:OXB) Stock Passes Above 200-Day Moving Average - Should You Sell?February 13, 2025 | marketbeat.com Get Oxford Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OXB Media Mentions By Week OXB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OXB News Sentiment▼0.120.56▲Average Medical News Sentiment OXB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OXB Articles This Week▼41▲OXB Articles Average Week Get the Latest News and Ratings for OXB and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Oxford Biomedica and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Genus News Oxford Nanopore Technologies News PureTech Health News Avacta Group News Faron Pharmaceuticals Oy News Bioventix News 4basebio News Scancell News ImmuPharma News Hemogenyx Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:OXB) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Biomedica plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Biomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
